These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15283299)

  • 1. The effect of cysteine analogues on the excretion of urinary sulphate in the rat following cysteine administration.
    Roopnarinsingh ES; Steventon GB; Harris RM; Waring RH; Mitchell SC
    Drug Metabol Drug Interact; 2004; 20(1-2):1-10. PubMed ID: 15283299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cysteine dioxygenase activity by oral administration of cysteine analogues to the rat: implications for drug efficacy and safety.
    Roopnarinesingh ES; Steventon GB; Harris RM; Waring RH; Mitchell SC
    Drug Metabol Drug Interact; 2005; 21(2):75-86. PubMed ID: 16355974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man.
    Waring RH; Harris RM; Steventon GB; Mitchell SC
    Drug Metabol Drug Interact; 2003; 19(4):241-55. PubMed ID: 14768973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation in the metabolism of S-carboxymethyl-L-cysteine in humans.
    Steventon GB
    Drug Metab Dispos; 1999 Sep; 27(9):1092-7. PubMed ID: 10460812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of [14C]- and [35S]S-(1,2-dichlorovinyl)-L-cysteine in the male Fischer 344 rat.
    Finkelstein MB; Patel NJ; Anders MW
    Drug Metab Dispos; 1995 Jan; 23(1):124-8. PubMed ID: 7720515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine metabolism: in vitro studies of S-oxidation mechanisms.
    Pilkington AE; Waring RH
    Drug Metabol Drug Interact; 1988; 6(1):85-93. PubMed ID: 3234004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion and biotransformation of carboxymethyl-cysteine in rat, dog, monkey and man.
    Turnbull LB; Teng L; Kinzie JM; Pitts JE; Pinchbeck FM; Bruce RB
    Xenobiotica; 1978 Oct; 8(10):621-8. PubMed ID: 102086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into possible xenobiotic-endobiotic inter-relationships involving the amino acid analogue drug, S-carboxymethyl-L-cysteine and plasma amino acids in humans.
    Steventon GB; Mitchell SC; Angulo S; Barbas C
    Amino Acids; 2012 May; 42(5):1967-73. PubMed ID: 21559953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between bucillamine and D-penicillamine in the treatment of rheumatoid arthritis.
    Kim HA; Song YW
    Rheumatol Int; 1997; 17(1):5-9. PubMed ID: 9194208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of S-(carboxymethyl)-L-cysteine and thiodiglycolic acid, urinary metabolites of 2,2'-bis-(chloroethyl)-ether in the rat.
    Müller G; Norpoth K; Eckard R
    Cancer Lett; 1979 Sep; 7(5):299-305. PubMed ID: 509409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxidation of L- and D-cysteine to inorganic sulfate and taurine in the rat.
    Krijgsheld KR; Glazenburg EJ; Scholtens E; Mulder GJ
    Biochim Biophys Acta; 1981 Sep; 677(1):7-12. PubMed ID: 7295791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free-radical degradation of high-molecular-weight hyaluronan induced by ascorbate plus cupric ions. Testing of bucillamine and its SA981-metabolite as antioxidants.
    Valachová K; Hrabárová E; Priesolová E; Nagy M; Baňasová M; Juránek I; Soltés L
    J Pharm Biomed Anal; 2011 Nov; 56(3):664-70. PubMed ID: 21782370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of congruence between cysteine dioxygenase activity and S-carboxymethyl-L-cysteine S-oxidation activity in rat cytosol.
    Khan S; Mitchell SC; Steventon GB
    J Pharm Pharmacol; 2004 Aug; 56(8):993-1000. PubMed ID: 15285843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine analogues potentiate glucose-induced insulin release in vitro.
    Ammon HP; Hehl KH; Enz G; Setiadi-Ranti A; Verspohl EJ
    Diabetes; 1986 Dec; 35(12):1390-6. PubMed ID: 3533685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of S-carboxymethyl-L-cysteine on pulmonary sialyl transferase activity in vitro, in healthy and in sulphur-dioxide-induced bronchitic rats.
    Berry CN; Lloyd KG; Louisot P
    Fundam Clin Pharmacol; 1992; 6(1):29-35. PubMed ID: 1555809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of 3-mercaptolactate-cysteine mixed disulfide, sulfate and taurine in human urine before and after oral administration of sulfur-containing amino acids.
    Yuasa S; Akagi R; Ubuka T; Masuoka N; Yao K
    Acta Med Okayama; 1990 Jun; 44(3):117-22. PubMed ID: 2382576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of inorganic mercury co-administrated with L-cysteine.
    Zalups RK; Barfuss DW
    Toxicology; 1996 May; 109(1):15-29. PubMed ID: 8619249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Mitchell SC; Waring RH; Haley CS; Idle JR; Smith RL
    Br J Clin Pharmacol; 1984 Oct; 18(4):507-21. PubMed ID: 6487492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of L-cysteine, L-cysteine derivatives and ascorbic acid on lead excretion in rats.
    McNiff EF; Cheng LK; Woodfield HC; Fung HL
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):131-7. PubMed ID: 663395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism and elimination of S-carboxymethyl-L-cysteine in man.
    Waring RH; Mitchell SC
    Drug Metab Dispos; 1982; 10(1):61-2. PubMed ID: 6124385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.